Conditions: Advanced Malignant Solid Neoplasm; Cancer Fatigue; Metastatic Malignant Solid Neoplasm; Pain; Recurrent Malignant Solid Neoplasm
Interventions: Other: Placebo; Other: Quality-of-Life Assessment; Other: Questionnaire Administration; Other: Waiting List
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting
ClinicalTrials.gov: Oncology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
Condition: Glioblastoma
Interventions: Procedure: Computed Tomography; Other: Fluciclovine F18; Procedure: Positron Emission Tomography
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Not yet recruiting
ClinicalTrials.gov: Oncology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
April 24, 2019ClinicalTrials.govComments OffOncologyAssessing | Fluciclovine | Glioblastoma | Patients | PET/CT | Radiation | Response | Surgery | Therapy | Tumor | Undergoing | Volume
Conditions: Small Cell Lung Cancer Extensive Stage; Small-cell Lung Cancer
Interventions: Drug: Durvalumab; Drug: Tremelimumab; Drug: Olaparib Pill; Radiation: Thoracic Radiotherapy
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; AstraZeneca
Not yet recruiting
ClinicalTrials.gov: Oncology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
April 23, 2019ClinicalTrials.govComments OffOncologyCancer | Cell | Combo | Durvalumab/Durvalumab | Lung | Radiotherapy | Small | Tremelimumab/Olaparid
Conditions: Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Carcinoma
Intervention:
Sponsors: University of Minnesota – Clinical and Translational Science Institute; United States Department of Defense
Not yet recruiting
ClinicalTrials.gov: Oncology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
April 22, 2019ClinicalTrials.govComments OffOncologyCancer | Cytomegalovirus | Inflammation | Outcomes | Ovarian | Patient | Role | Symptoms
Condition: Prostate Cancer
Interventions: Drug: CTT1403; Drug: CTT1057 or 68Ga-PSMA-11
Sponsors: Cancer Targeted Technology; University of California, San Francisco
Recruiting
ClinicalTrials.gov: Oncology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
April 21, 2019ClinicalTrials.govComments OffOncologyCancer | Castration | CTT1403 | Metastatic | Prostate | Resistant | Trial
